serb

Private

Last Round

Debt

Jul 15, 2025

Est. Valuation

$756M

Total Funding Raised

Company Overview

The latest recorded funding round for serb was a Private Equity round in June 2023. serb was founded in 1951.

A specialty pharmaceutical group focused on prescription medicines for rare and life-threatening diseases.

Historical view of private secondary pricing and transaction trends.

Caplight clients see full MarketPrice™ history and secondary transactions.

For institutional investors. Book with your work email.

Proprietary index based on bid/ask volume and sentiment.

Caplight clients track how buyer interest and sentiment change over time.

For institutional investors. Book with your work email.

Compare serb with similar companies based on industry and business-model similarity.

No comparables are published for serb. Book a demo to ask about coverage.

For institutional investors. Book with your work email.

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jul 15, 2025	Demo	Demo	Demo	Demo
Private Equity	Jun 8, 2023	Demo	Demo	Demo	Demo
Private Equity	Feb 28, 2021	Demo	Demo	Demo	Demo
Buyout/LBO	Jun 9, 2017	Demo	Demo	Demo	Demo

For institutional investors. Book with your work email.

Explore SEC and related filing metadata, where available.

serb filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

For institutional investors. Book with your work email.

Headquarters—

Year Founded1951

Last FundingJul 15, 2025

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

For institutional investors. Book with your work email.

See something wrong or outdated?